Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler), a specialist for isotope technology for medical, scientific and industrial applications, has acquired their competitor Gamma-Service. With companies in Switzerland, Germany, and the Czech Republic, Gamma-Service is a specialist in the manufacture of isotope technology products for medicine and industry and generated a turnover of approximately EUR 20 million in the business year 2016.
Eckert & Ziegler AG, which is listed on the stock exchange of Frankfurt on the Main, has approximately 610 employees and is one of the world’s largest providers of isotope technology components for radiation therapy and nuclear medicine.
An international team under the guidance of Dr. Steffen Fritzsche (GRUENDELPARTNER) has comprehensively advised Eckert & Ziegler AG within the scope of due diligence as well as contract drafting and negotiations. GRUENDELPARTNER has already previously supported Eckert & Ziegler regarding the preparation of prospectuses for capital measures as well as strategic investments.
Dr. Steffen Fritzsche (Lead, Corporate, Berlin),
Dr. Mirko Gründel (Corporate), Steffen Tietze (Employment),
Florian Helbig, Theresa Thümmler, Anne Schwanke
(all Commercial, all from Leipzig)
- Berry Smith LLP:
Andrew Bound, Paul Evans (both Corporate, both from Cardiff)
- Havel Holasek & Partner:
Pavel Nemecek, Petra Tomsu, Juraj Petro
(all Corporate / Commercial, all from Prague)
- Wenner & Uhlmann:
Dr. Christoph Born, Dr. Andreas Blattmann
(both Corporate, both from Zurich)
Mädler-Passage, Grimmaische Str. 2-4
Tel.: +49 341 231062-0
Fax: +49 341 231062-30